Regulus Therapeutics
RGLS
#8814
Rank
NZ$0.16 B
Marketcap
$2.51
Share price
5.00%
Change (1 day)
13.23%
Change (1 year)

Regulus Therapeutics (RGLS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$10.13 Million

According to Regulus Therapeutics's latest financial reports the company's total liabilities are NZ$10.13 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regulus Therapeutics - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$21.14 M7.02%
2021-12-31NZ$19.75 M23.14%
2020-12-31NZ$16.04 M-51.03%
2019-12-31NZ$32.76 M-34.94%
2018-12-31NZ$50.36 M-16.03%
2017-12-31NZ$59.97 M-6.83%
2016-12-31NZ$64.36 M159.06%
2015-12-31NZ$24.84 M-50.67%
2014-12-31NZ$50.37 M39.8%
2013-12-31NZ$36.02 M-28.45%
2012-12-31NZ$50.35 M-53.42%
2011-12-31NZ$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$101.84 B 1,005,022.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$103.82 B 1,024,549.71%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$20.39 B 201,218.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$110.47 B 1,090,199.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$7.12 B 70,170.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B 1,067.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$130.48 B 1,287,707.34%๐Ÿ‡บ๐Ÿ‡ธ USA